|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 186.58 USD | -1.76% |
|
+0.38% | -11.03% |
| Dec. 09 | ICON plc Releases Findings from Two Biotech Sector Survey | CI |
| Dec. 02 | Icon survey reveals increasing clinical trial startup delays | RE |
Company Valuation: ICON Public Limited Company
Data adjusted to current consolidation scope
| Fiscal Period: December | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 10,290 | 25,209 | 15,860 | 23,304 | 17,314 | 14,247 | - | - |
| Change | - | 144.98% | -37.09% | 46.94% | -25.71% | -17.71% | - | - |
| Enterprise Value (EV) 1 | 9,797 | 29,891 | 20,223 | 26,700 | 20,201 | 17,269 | 16,767 | 15,691 |
| Change | - | 205.12% | -32.34% | 32.03% | -24.34% | -14.51% | -2.91% | -6.42% |
| P/E ratio | 31.7x | 138x | 31.7x | 38.3x | 22x | 28.9x | 19.4x | 17.9x |
| PBR | 5.56x | 3.13x | 1.87x | 2.53x | 1.78x | 1.53x | 1.39x | 1.27x |
| PEG | - | -2.2x | 0x | 1.8x | 0.8x | -0.9x | 0.4x | 2.02x |
| Capitalization / Revenue | 3.68x | 4.6x | 2.05x | 2.87x | 2.09x | 1.76x | 1.75x | 1.68x |
| EV / Revenue | 3.5x | 5.45x | 2.61x | 3.29x | 2.44x | 2.14x | 2.06x | 1.85x |
| EV / EBITDA | 20.6x | 30.8x | 13.7x | 15.8x | 11.6x | 10.9x | 10.7x | 9.45x |
| EV / EBIT | 23.9x | 45.6x | 14.7x | 17x | 12.6x | 12.2x | 12.1x | 10.7x |
| EV / FCF | 19x | 40.6x | 48x | 26.2x | 18.1x | 19.1x | 16.8x | 15.4x |
| FCF Yield | 5.28% | 2.46% | 2.08% | 3.82% | 5.54% | 5.23% | 5.95% | 6.48% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | 6.15 | 2.25 | 6.13 | 7.4 | 9.53 | 6.459 | 9.6 | 10.45 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 2,797 | 5,481 | 7,741 | 8,120 | 8,282 | 8,076 | 8,126 | 8,502 |
| EBITDA 1 | 475.7 | 970 | 1,479 | 1,694 | 1,736 | 1,580 | 1,561 | 1,660 |
| EBIT 1 | 409.6 | 655 | 1,373 | 1,568 | 1,598 | 1,420 | 1,386 | 1,463 |
| Net income 1 | 332.3 | 153.2 | 505.3 | 612.3 | 791.5 | 556.4 | 726.4 | 836.2 |
| Net Debt 1 | -493.6 | 4,682 | 4,364 | 3,396 | 2,887 | 3,022 | 2,520 | 1,443 |
| Reference price 2 | 194.98 | 309.70 | 194.25 | 283.07 | 209.71 | 186.58 | 186.58 | 186.58 |
| Nbr of stocks (in thousands) | 52,775 | 81,398 | 81,645 | 82,327 | 82,559 | 76,360 | - | - |
| Announcement Date | 2/24/21 | 2/22/22 | 2/22/23 | 2/21/24 | 2/19/25 | - | - | - |
1USD in Million2USD
Estimates
P/E ratio, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 28.89x | 2.14x | 10.93x | -.--% | 14.25B | |
| 36.03x | 5.24x | 17.55x | 0.96% | 45.43B | |
| 31.29x | 3.16x | 13.65x | -.--% | 37.85B | |
| 102.5x | 6.24x | 62.58x | -.--% | 35.31B | |
| 52.47x | 10.12x | 28.62x | 0.4% | 27.66B | |
| 37.69x | 6.1x | 27.7x | -.--% | 15.72B | |
| -14.13x | 5514.01x | -13.31x | -.--% | 15.26B | |
| -56.36x | 15.84x | -129.84x | -.--% | 13.47B | |
| -35.99x | 13.58x | -38.79x | -.--% | 13.09B | |
| -47.51x | 10.27x | 26431.56x | -.--% | 12.56B | |
| Average | 13.49x | 558.67x | 2,641.06x | 0.14% | 23.06B | |
| Weighted average by Cap. | 29.72x | 371.35x | 1,450.53x | 0.24% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Equities
- ICLR Stock
- Valuation ICON Public Limited Company
Select your edition
All financial news and data tailored to specific country editions
